PSS20 COST-EFFECTIVENESS OF TOBRADEX VERSUS ZYLET FOR THE TREATMENT OF BLEPHAROKERATOCONJUNCTIVITIS
May 1, 2008, 00:00
10.1016/S1098-3015(10)70915-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70915-3/fulltext
Title :
PSS20 COST-EFFECTIVENESS OF TOBRADEX VERSUS ZYLET FOR THE TREATMENT OF BLEPHAROKERATOCONJUNCTIVITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70915-3&doi=10.1016/S1098-3015(10)70915-3
First page :
Section Title :
Open access? :
No
Section Order :
675